Stuart Poulton Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Stuart Poulton is EVP, Chief Development Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 326,628 shares of KPTI, which is worth approximately $254,769. The most recent transaction as insider was on Jul 30, 2024, when has been sold 2,883 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $3,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
327K
0%
3M change
108.99%
12M change
Total Value Held
$254,769
Stuart Poulton Transaction History
SP
Stuart Poulton
EVP, Chief Development Officer
Newton, MA